Cell & Gene
Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...
March 14, 2025 | Interaction
CARsgen Doses First SLE Patient with KJ-C2219, a Dual-Target Allogeneic CAR-T Therapy
CARsgen Therapeutics Holdings Limited a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tu...
February 28, 2025 | News
CARsgen Therapeutics and Zhuhai SB Xinchuang Partner to Advance Allogeneic CAR-T Therapies in China
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
February 26, 2025 | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute’s CNS Capsids to Advance Gene Therapy for Neurological Diseases
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expand...
February 21, 2025 | News
Restore Vision Doses First Patient in World’s First Optogenetic Gene Therapy Trial for Retinitis Pigmentosa
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. R...
February 14, 2025 | News
Lion TCR Secures FDA Clearance for Phase 2 Trial of Pioneering mRNA TCR-T Therapy for Liver Cancer
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug A...
February 12, 2025 | News
PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies
PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop pr...
February 12, 2025 | News
Bristol Myers Squibb’s Breyanzi Recommended for EU Approval After 97% Response Rate in Follicular Lymphoma
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving comple...
February 03, 2025 | News
VectorBuilder’s Partner Ucello Secures FDA IND Approval for UC101, the World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Therapy
VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investi...
January 30, 2025 | News
CPC Introduces MicroCNX® Nano Series Connectors to Streamline Cell and Gene Therapy Processing
CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutic...
January 30, 2025 | News
GC Cell Hosts Landmark Symposium in Indonesia to Spotlight Immuncell-LC Cancer Immunotherapy
GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia....
January 24, 2025 | News
CARsgen Therapeutics Administers First Dose of KJ-C2320 Allogeneic CAR T-Cell Therapy in Investigator-Initiated Trial
CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...
January 21, 2025 | News
YolTech Therapeutics Launches Clinical Trial for YOLT-204 a First-in-Class Gene Editing Therapy for Beta-Thalassemia
YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for Y...
January 21, 2025 | News
Charles River and Akron Bio Advance Cell Therapy Manufacturing with Integration of Closed System Cytokines
Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio (“Akron”), a leading supplier of critical materials and services for a...
January 17, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
